RTW Biotech Opportunities invests in Alesta Therapeutics’ €65 million series A round

LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focusing on high-growth potential assets in the life sciences sector, has announced a new investment in Alesta Therapeutics. The Netherlands-based biotechnology firm, Alesta, is dedicated to developing novel oral small molecule therapies for rare, underserved diseases. Alesta Therapeutics recently completed a €65 million (US$67…

Fay raises $25 million in Series A round by Forerunner Ventures

To address the growing health crisis related to dietary habits, San Francisco-based startup Fay has announced a substantial $25 million funding round. This significant financial boost comes on the heels of a previously undisclosed seed round led by General Catalyst and a $20 million Series A round spearheaded by Forerunner Ventures, with continued support from…